Inhibikase Therapeutics Plans Participation in Jefferies and Evercore Healthcare Conferences

PUBT · 2d ago
Inhibikase Therapeutics Plans Participation in Jefferies and Evercore Healthcare Conferences
  • Inhibikase Therapeutics will attend the Jefferies Global Healthcare Conference in London Nov. 16-19, 2026.
  • CEO Mark Iwicki joins Jefferies Research’s Dennis Ding for a fireside chat Nov. 16 at 3 p.m. GMT.
  • Management will hold one-on-one meetings Nov. 16-17.
  • The company will also attend the 9th Annual Evercore Healthcare Conference in Coral Gables, Florida, Nov. 30-Dec. 2, 2026.
  • One-on-one meetings at the Evercore conference are scheduled for Dec. 1.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhibikase Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610270800PRIMZONEFULLFEED9853493) on October 27, 2026, and is solely responsible for the information contained therein.